LabGenius' CEO & founder appeared live on Bloomberg News to talk about the drug discovery revolution that's taking place at the interface of biology and technology

---

About LabGenius

Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of novel therapeutic antibodies. LabGenius’ highly multidisciplinary team brings together the very best minds from the fields of drug discovery, computer science, robotic automation and synthetic biology.

For more information, please visit www.labgeni.us, or connect on Twitter, LinkedIn and Medium.

For more information, please contact:

Media enquiries:
Communications Lead
Lucy Shaw
press@labgeni.us

Business development:
Founder & CEO
James Field
partnerships@labgeni.us

---